Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers : safety and immunogenicity

Copyright 2009 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 134(2010), 2 vom: 15. Feb., Seite 113-20
1. Verfasser: Salemi, S (VerfasserIn)
Weitere Verfasser: Picchianti-Diamanti, A, Germano, V, Donatelli, I, Di Martino, A, Facchini, M, Nisini, R, Biselli, R, Ferlito, C, Podestà, E, Cappella, A, Milanetti, F, Rossi, F, Amodeo, R, Tabacco, F, Di Rosa, R, Laganà, B, D Amelio, R
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2010
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Clinical Trial Journal Article Research Support, Non-U.S. Gov't Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Viral Antigens, Viral Antirheumatic Agents Immunoglobulin G Influenza Vaccines mehr... Receptors, Tumor Necrosis Factor Tumor Necrosis Factor-alpha Infliximab B72HH48FLU Adalimumab FYS6T7F842 Etanercept OP401G7OJC